Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser vs Benzydamine for Oral Mucositis
NCT05034068Phase 1Completed
- Sponsor
- Al-Azhar University
- Start
- Oct 2021
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of benzydamine in oral mucositis (OM) (3 arms), sponsored by Al-Azhar University. Primary endpoints: Tumor Necrosis Factor-alpha at 7 weeks, Interleukin-6 at 7 weeks and 3 more. Started Oct 2021; status: completed.
02
Drugs
benzydamine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05034068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05034068.